Effects of a proteasome inhibitor on the NF-κB signalling pathway in experimental osteoarthritis.

Scandinavian journal of rheumatology

Volumn 42, Issue 5, 2013, Pages 400-407

  Quan, R ^a   Huang, Z ^b   Yue, Z ^b   Xin, D ^b   Yang, D ^b   Pan, J ^b   Zhang, L ^b  

^a Xiaoshan Traditional Chinese Medical Hospital   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CHYMOTRYPSIN; CYSTEINE PROTEINASE INHIBITOR; I KAPPA B; INTERLEUKIN 1BETA; LEUPEPTIN; PEPTIDYLGLUTAMYLPEPTIDE HYDROLASE; PROTEASOME; PROTEINASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL EXPERIMENT; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; ARTICULAR CARTILAGE; DISEASE MODEL; DRUG EFFECT; GENETICS; MALE; METABOLISM; OSTEOARTHRITIS; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; SYNOVIUM;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; CARTILAGE, ARTICULAR; CHYMOTRYPSIN; CYSTEINE PROTEINASE INHIBITORS; DISEASE MODELS, ANIMAL; ENDOPEPTIDASES; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; LEUPEPTINS; MALE; OSTEOARTHRITIS; PHYSICAL CONDITIONING, ANIMAL; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887329412     PISSN: None     EISSN: 15027732     Source Type: None    
DOI: 10.3109/03009742.2013.776101     Document Type: Article

References (0)